News & Updates

Unemployment, difficulties regarding household finances, and a perceived decrease in general support lead to greater anxiety and depression burden in pregnant women during the coronavirus disease 2019 (COVID-19) pandemic, reports a recent meta-analysis.

The progression of COVID-19 disease during pregnancy from asymptomatic or mild symptoms to moderate, severe, or critical symptoms is consistent regardless of trimester, according to a prospective study presented at SMFM 2022.

Universal screening for hepatitis C virus (HCV) in pregnant individuals resulted in improved detection and a potential reduction in perinatal transmission, according to a study presented at CROI 2022.

Hypertensive disorders in pregnancy seem to aggravate the risk of premature delivery and intrauterine growth retardation, reports a recent study. Consequentially, the delivered infants may be more likely to sustain injuries to the cardiovascular and endocrine system and suffer from neurodevelopmental delays.

Common blood pressure (BP)-lowering medications in pregnancy cut the risk of severe hypertension, but labetalol has the added advantage of reducing the risks of proteinuria or pre-eclampsia and perinatal death, according to the results of a network meta-analysis.